Dr Mark Lovern is Executive Director of Medical Science Services at Fortrea, and has 25+ years of experience in the application of model-informed drug development (MIDD).
Smarter, faster, better: How AI is reshaping neuroscience clinical trials
How can neuroscience clinical trial sponsors use AI to reduce complexity, accelerate timelines and lower costs in a high-risk, delay-prone research environment?